LAB21 acquires Microgen Bioproducts - MarketLine Financial Deals

LAB21 acquires Microgen Bioproducts

LAB21 acquires Microgen Bioproducts - MarketLine Financial Deals
LAB21 acquires Microgen Bioproducts
Published Jan 06, 2011
2 pages — Published Jan 06, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Lab21, Ltd., a provider of diagnostic products and services to pharmaceutical and biotechnology companies, has acquired Microgen Bioproducts, Ltd., a developer and manufacturer of diagnostic products for clinical, food, industrial veterinary and environmental testing.

  
Source:
Document ID
MA45699_110110
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "LAB21 acquires Microgen Bioproducts" Jan 06, 2011. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/LAB21-acquires-Microgen-Bioproducts-2052-50758>
  
APA:
MarketLine Financial Deals. (2011). LAB21 acquires Microgen Bioproducts Jan 06, 2011. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/LAB21-acquires-Microgen-Bioproducts-2052-50758>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.